The modified Baveno classification for obstructive sleep apnoea: development and evaluation based on the ESADA database
Makaleler > Tam Makale · 2024
Yazarlar: Sandhya Matthes, Marcel Treml, Ludger Grote, Jan Hedner, Ding Zou, Maria R. Bonsignore, Jean-Louis Pépin, Sébastien Bailly, Silke Ryan, Walter T. McNicholas, Sofia E. Schiza, Johan Verbraecken, Athanasia Pataka, Paweł Śliwiński, Özen KAÇMAZ BAŞOĞLU, Carolina Lombardi, Gianfranco Parati, Winfried J. Randerath
European Respiratory Journal, Uluslararası, Wos, 2024, cilt 64, ss 2401371-2401371
DOI: 10.1183/13993003.01371-2024
Özet
BACKGROUND: The "Baveno classification" replaced the apnoea-hypopnoea index (AHI) with symptoms and comorbidities for treatment indication in obstructive sleep apnoea (OSA). This study evaluates a modified Baveno classification which adds a validated cardiovascular disease (CVD) risk score and acknowledges severe breathing disturbances. METHOD: , symptoms and CVD risk dictated allocation to the weak, intermediate or strong treatment indication group. Changes in Epworth Sleepiness Scale (ESS) score and office systolic blood pressure (SBP) at follow-up (12-24 months) under positive airway pressure (PAP) were assessed. RESULTS: . CONCLUSION: This analysis provides supporting evidence for the key role of CVD risk assessment and severe breathing disturbances in the identification of OSA patients most likely to benefit from treatment.